Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

206
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
206
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

575
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
575
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

149
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
149
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

110
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
110

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescription.

European heart journal·2026
Same author

Magnitude of and outcome associated with inappropriate prescribing in heart failure with reduced ejection fraction: an analysis of 50 348 patients from the Swedish Heart Failure Registry.

European journal of heart failure·2026
Same author

Sex differences in the use of blood pressure lowering therapy and blood pressure control.

Journal of hypertension·2026
Same author

Proteomics-based clustering outperforms clinical clustering in identifying people with heart failure with distinct outcomes.

Communications medicine·2025
Same author

The association of Life's Essential 8 with risk of stroke: The EPIC-NL prospective cohort study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2025
Same author

Comparing Life's Simple 7 and Life's Essential 8 With Risk of Heart Failure.

JACC. Advances·2025

Related Experiment Video

Updated: Dec 18, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.9K

A registry-based algorithm to predict ejection fraction in patients with heart failure.

Alicia Uijl1,2,3, Lars H Lund1,4, Ilonca Vaartjes2

  • 1Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

ESC Heart Failure
|June 18, 2020
PubMed
Summary

An algorithm using routine clinical data can identify heart failure (HF) subtypes, including HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF). This aids research when ejection fraction (EF) is missing, though accuracy for mid-range EF (HFmrEF) is lower.

Keywords:
Ejection fractionElectronic health recordsHFmrEFHFpEFHFrEFHeart failurePrediction

More Related Videos

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.6K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

456

Related Experiment Videos

Last Updated: Dec 18, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.9K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.6K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

456

Area of Science:

  • Cardiology
  • Medical Informatics
  • Epidemiology

Background:

  • Left ventricular ejection fraction (EF) is crucial for classifying heart failure (HF) into HF with preserved (HFpEF), mid-range (HFmrEF), and reduced (HFrEF) EF categories.
  • EF is frequently unavailable in large population-based cohorts and non-HF registries, hindering comprehensive HF research.

Purpose of the Study:

  • To develop and validate an algorithm for identifying EF subphenotypes (HFpEF, HFmrEF, HFrEF) using routinely collected clinical characteristics.
  • To enable robust research on HF within big data settings where EF measurements are often absent.

Main Methods:

  • Utilized logistic regression and multivariable multinomial analysis on 42,061 HF patients from the Swedish Heart Failure Registry.
  • Included 22 clinical variables to predict EF categories: EF ≥50% vs. <50%, EF ≥40% vs. <40%, and the three distinct subphenotypes (HFrEF, HFmrEF, HFpEF).
  • Validated the models using data from the CHECK-HF study (10,627 patients) in the Netherlands.

Main Results:

  • The algorithm demonstrated good discriminative ability for predicting HFpEF (C-statistic 0.78) and HFrEF (C-statistic 0.76).
  • Accuracy for identifying HFmrEF was lower (C-statistic 0.63).
  • External validation confirmed similar predictive performance in an independent cohort.

Conclusions:

  • Routine clinical data can effectively identify HF subphenotypes, particularly HFpEF and HFrEF, in large datasets lacking direct EF measurements.
  • The developed algorithm facilitates large-scale research on HF epidemiology and outcomes.
  • Further refinement may be needed to improve the accuracy of HFmrEF classification.